What is Endo-Systems?
Endo-Systems specializes in endermologie® non-invasive cellulite treatment and body contouring solutions, catering to beauty, health, and med-aesthetic professionals. As a subsidiary of LPG Group, the company leverages innovative technology to enhance service offerings for businesses, aiming to deliver rapid total body results for clients. Their product portfolio, including the Cellu M6 Alliance and Mobi M6, is designed to foster significant financial growth opportunities for partners by improving client satisfaction and retention within spas, medical practices, and wellness centers.
How much funding has Endo-Systems raised?
Endo-Systems has raised a total of $68K across 1 funding round:
Debt
$68K
Debt (2021): $68K with participation from PPP
What's next for Endo-Systems?
With the recent influx of substantial expansion capital, Endo-Systems is poised for accelerated growth and market penetration. The company's strategic focus will likely involve scaling its operations, enhancing its technological offerings, and expanding its reach within the med-aesthetic and wellness sectors. This investment is expected to fuel further innovation in non-invasive body contouring solutions, reinforcing its position as a key player in the industry and driving enhanced value for its professional partners.
See full Endo-Systems company page
